[Pharmacologist against atherosclerosis].
Gryglewski
R
R
Katedry Farmakologii Collegium Medicum Uniwersytetu Jagiellońskiego w Krakowie.
D001161:Arteriosclerosis / Q000188:drug therapy / Q000266:history*; D011464:Epoprostenol / Q000266:history* / Q000627:therapeutic use; D049672:History, 19th Century; D049673:History, 20th Century; D010975:Platelet Aggregation Inhibitors / Q000266:history* / Q000627:therapeutic use; D011044:Poland; D013928:Thromboxane A2 / Q000096:biosynthesis / Q000266:history
D010975:Platelet Aggregation Inhibitors; D013928:Thromboxane A2; D011464:Epoprostenol